Resolve Therapeutics
PrivateLast Round
Series B
Nov 1, 2012
Total Funding Raised
$7.8M
Company Overview
Resolve Therapeutics is a biotechnology company that develops non-immunosuppressive biologic therapies for the treatment of autoimmune diseases such as lupus and Sjögren's syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resolve Therapeutics Comparables
Compare Resolve Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bristol Myers Squibb | 79% | |
| Rise Therapeutics | 70% | |
| Novartis | 67% | |
Resolve Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 1, 2012 | ||||
| Series A | May 17, 2011 |
Resolve Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Washington Research Foundation Capital | Series B |
| Easton-Hunt Capital Partners, L.P. | Series B, Series A |
| New Science Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2012
$6M round led by New Science Ventures.
- May 17, 2011
$2M round led by Easton-Hunt Capital Partners and New Science Ventures.
Resolve Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Resolve Therapeutics's valuation, stock price, and market status.